Dozee baggage $8M for international growth
Dozee is looking for to enter new worldwide markets following its newest fundraising.
The Indian medical machine maker raised INR 71.5 crore ($8.3 million) from Temasek Belief’s C3H and different traders.
“Past the [United States], we’re exploring new worldwide markets whereas broadening our product portfolio to cowl the whole continuum of care — from hospitals to transition care and residential settings,” an organization spokesperson stated in an announcement shared with Mobihealth Information.
The corporate, which provides an AI-powered contactless important indicators monitoring and alert system, raised $6 million in a second Collection A funding spherical in 2023 to kickstart its growth.
JLK scores 4th Japan PMDA clearance
South Korean medical AI firm JLK has introduced new regulatory clearance for one in every of its stroke AI software program merchandise.
It obtained its fourth approval from Japan’s Prescribed drugs and Medical Units Company (PMDA) for its MRI FLAIR-based (Fluid-Attenuated Inversion Restoration) software program.
The answer analyses, visualises, and measures high-intensity areas in MRI-FLAIR sequence photographs, which helps in evaluating therapy choices for sufferers with acute ischemic stroke and predicting cognitive decline and dementia threat.
The corporate obtained its final PMDA approval for its non-contrast CT stroke AI software program in February.
Coreline Mushy secures new US FDA, Korea MFDS approvals
One other medical AI firm, Coreline Mushy, has additionally obtained new regulatory approvals in South Korea and the USA.
It obtained its eleventh 510(okay) certification from the USA Meals and Drug Administration for its upgraded flagship medical picture evaluation software program. The software program, now dubbed AVIEW 2.0options an optimised person interface and enhanced accessibility, safety, stability, and communication perform.
The corporate was additionally awarded Class 3 approval from South Korea’s Ministry of Meals and Drug Security for AVIEW LCS, its AI-based software program for predicting the malignancy of pulmonary nodules.
Well being genAI platform baggage $500,000
Singaporean startup FlocCare has just lately raised $500,000 in funding from DTVP, SDTA Ventures and different angel traders.
Based in 2023, the corporate develops giant language fashions for producing personalised medical info for hospitals, healthcare professionals, and sufferers. It claims its fashions are “50 occasions sooner, fact-checked, scalable and regulatory-compliant.”
In a press assertion, FlocCare stated it might use its recent funds to develop its genAI fashions to extra illness classes, together with cardiovascular ailments, persistent kidney illness, ladies’s well being, and oncology.
It additionally plans to introduce its AI fashions within the United Arab Emirates, in addition to onboard new group members.
Source link
